Adjuvant Dendritic Cell-immunotherapy Plus Temozolomide in Glioblastoma Patients

Clinical trial NCT02649582 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02649582
Sponsor: University Hospital, Antwerp
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Glioblastoma Multiforme of Brain

Start date: 2015-12-01
Primary completion: 2027-07-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.